127
Views
22
CrossRef citations to date
0
Altmetric
Research Article

Fibroblast growth factor and ex vivo expansion of hematopoietic progenitor cells

&
Pages 329-333 | Published online: 01 Jul 2009

REFERENCES

  • Armelin HA. Pituitary extracts and steroid hormones in the control of 3T3 cell growth. Proceedings of The National Academy of Sciences of The United States of America 1973;70:2702–2706.
  • Gospodarowicz D. Localisation of a fibroblast growth factor and its effect alone and with hydrocortisone on 3T3 cell growth. Nature 1974;249:123–127.
  • Basilico CD, Moscatelli. The FGF family of growth factors and oncogenes. Advances in Cancer Research 1992;59:115–165.
  • Baird A. Fibroblast growth factors: Activities and significance of non-neurotrophin neurotrophic growth factors. Current Opinion in Neurobiology 1994;4:78–86.
  • Klagsbrun M, Baird A. A dual receptor system is required for basic fibroblast growth factor activity. Cell 1991;67:229–231.
  • Braun S, auf dem Keller U, Steiling H, Werner S. Fibroblast growth factors in epithelial repair and cytoprotection. Philosophical Transactions of the Royal Society of London Series B-Biologic 2004;29:753–757.
  • Ziche M, Donnini S, Morbidelli L. Development of new drugs in angiogenesis. Current Drug Targets 2004;5:485–493.
  • Powers CJ, McLeskey SW, Wellstein A. Fibroblast growth factors, their receptors and signaling. Endocrine-Related Cancer 2000;7:165–197.
  • Martin I, Muraglia A, Campanile G, Cancedda R, Quarto R. Fibroblast growth factor-2 supports ex vivo expansion and maintenance of osteogenic progenitor cells from human bone marrow. Endocrinology 1997;138: 4456–4462.
  • Walsh S, Jefferiss C, Stewart K, Jordan GR, Screen J, Beresford JN. Expression of the developmental markers STRO-1 and alkaline phosphatase in cultures of human marrow stromal cells: regulation by fibroblast growth factor (FGF)-2 and relationship to the expression of FGF receptors 1-4. Bone 2000;27:185–195.
  • Allouche M, Bikfalvi A. The role of fibroblast growth factor-2 (FGF-2) in hematopoiesis. Leukemia 1995;9:937–942.
  • Allouche M, Bayard F, Clamens S, Fillola G, Sie P, Amalric F. Expression of basic fibroblast growth factor (bFGF) and FGF-receptors in human leukemic cells. Leukemia 1995;9:77–86.
  • Yang M, Li K, Lam AC, Yuen PM, Fok TF, Chesterman CN, Chong BH. Platelet-derived growth factor enhances granulopoiesis via bone marrow stromal cells. International Journal of Hematology 2001;73:327–334.
  • Bikfalvi A, Hanm ZC, Fuhrmann G. Interaction of fibroblast growth factor (FGF) with megakaryocytopoiesis and demon-stration of FGF receptor expression in megakaryocytes and megakaryocytic-like cells. Blood (1992);80:1905–1913.
  • Chen QS, Wang ZY, Han ZC. Enhanced growth of megakaryocyte colonies in culture in the presence of heparin and fibroblast growth factor. International Journal of Hematology 1999;70:155–162.
  • de Haan G, Weersing E, Dontje B, van Os R, Bystrykh LV, Vellenga E, Miller G. In vitro generation of long-term repopulating hematopoietic stem cells by fibroblast growth factor-1. Developmental cell 2003;4: 241–251.
  • Koritschoner NP, Bartunek P, Knespel S, Blendinger G, Zenke M. The fibroblast growth factor receptor FGFR-4 acts as a ligand dependent modulator of erythroid cell prolifera-tion. Oncogene 1999;18: 5904–5914.
  • Gabrilove JL, White K, Rahman Z, Wilson EL. Stem cell factor and basic fibroblast growth factor are synergistic in augmenting committed myeloid progenitor cell growth. Blood 1994;83:907–910.
  • Dooley DC, Oppenlander BK, Spurgin P, Mead JH, Novak FP, Plunkett FP, Beckstead J, Heinrich MC. Basic fibroblast growth factor and epidermal growth factor downmodulate the growth of hematopoietic cells in long-term stromal cultures. Journal of Cellular Physiology 1995;165:386–397.
  • Quito FL, Beh J, Bashayan 0, Basilico C, Basch RS. Effects of fibroblast growth factor-4 (k-FGF) on long-term cultures of human bone marrow cells. Blood 1996;87: 1282–1291.
  • Wilson EL, Rifkin DB, Kelly F, Hannocks MJ, Gabrilove JL. Basic fibroblast growth factor stimulates myelopoiesis in long-term human bone marrow cultures. Blood 1991;77:954–960.
  • Berthier R, Prandini MH, Schweitzer A, Thevenon D, Martin-Sisteron H, Uzan G. The MS-5 murine stromal cell line and hematopoietic growth factors synergize to support the megakaryocytic differentiation of embryonic stem cells. Experimental Hematology 1997;25: 481–490.
  • Kashiwakura I, Tsuneo AT. Basic fibroblast growth factor-stimulated ex vivo expansion of haematopoietic progenitor cells from human placental and umbilical cord blood. British Journal of Haematology 2003;122:479–488.
  • Bruno E, Cooper RJ, Wilson EL, Gabrilove JL, Hoffman R. Basic fibroblast growth factor promotes the proliferation of human megakaryocyte progenitor cells. Blood 1993;82:430–435.
  • Han ZC, Bellucci S, Wan HY, Caen JP. New insights into the regulation of megakaryocytopoiesis by haematopoietic and fibroblastic growth factors and transforming growth factor beta 1. British Journal of Haematology 1992;81:1–5.
  • Konishi H, Ochiya T, Yasuda Y, Sakamoto H, Muto T, Sugimura T, Terada M. HST-1/FGF-4 stimulates prolifera-tion of megakaryocyte progenitors synergistically and promotes megakaryocyte maturation. Oncogene 1996;13: 9–19.
  • Matsumoto YS, Seko C, Kuroshima K, Naruo K, Shino A, Kondo T, Kurokawa T. Stimulation of thrombopoiesis in mice by fibroblast growth factor 9. Growth Factors 199512:179–190.
  • Avraham H, Banu N, Scadden DT, Abraham J, Groopman JE. Modulation of megakaryocytopoiesis by human basic fibroblast growth factor. Blood 1994;83:2126–2132.
  • Metcalf D. Hematopoietic regulators: redundancy or subtlety? Blood 1993;82:3515–3523.
  • Gallicchio VS, Hughes NK, Hulette BC, DellaPuca R, Noblitt L. Basic fibroblast growth factor (FGF-2) induces early- (CFU-s) and late-stage hematopoieticprogenitor cell colony formation (CFU-gm, CFU-meg, and BFU-e) by synergizing with GM-CSF, Meg-CSF, and erythropoietin, and is a radioprotective agent in vitro. International Journal of Cell Cloning 1991;9: 220–232.
  • Allouche M, Bikfalvi A. The role of fibroblast growth factor-2 (FGF-2) in hematopoiesis. Progress in Growth Factor Research 1995;6:35–48.
  • Han ZC, Bikfalvi A, Shen ZX, Bodevin E. Recombinant acidic human fibroblast growth factor (aFGF) stimulates murine megakaryocyte colony formation in vitro. Interna-tional Journal of Hematology 1992;55:281 —286.
  • Emami S, Merrill W, Cherington V, Chiang GG, KirchgesserM, Appel JM, Hansen M, Levine PH, Greenberger JS, Hurwitz DR. Enhanced growth of canine bone marrow stromal cell cultures in the presence of acid' fibroblast growth factor and heparin. In vitro Cellular & Developmental Biology Animal 1997;33:503 — 511.
  • Gabblaanelli M, Sargiacomo M, Pelosi E, Testa U, Isacchi G, Peschle C. "Pure" human hematopoietic progenitors: permissive action of basic fibroblast growth factor. Science 1990;28:1561 —1564.
  • Wilson EL, Ritkin DB, Kelly F, Hannocks MJ, Gabrilove JL. Basic fibroblast growth factor stimulates myelopoiesis in long-term human bone marrow cultures. Blood 1991;77:954–960.
  • Oliver 14, Ritkin DB, Gabrilove JL, Hannocks M, Wilson EL. Long-term culture of human bone marrow stromal cells in the presence of basic fibroblast growth factor. Growth Factors 1990;3:231 —236.
  • Lowry PA, Tabbara IA. Peripheral hematopoietic stem cell transplantation: current concepts. Experimental Hematology 1992;20:937–942.
  • Yoon SY, Tefferi A, Li CY. Cellular distribution of platelet-derived growth factor, transforming growth factor-beta, basic fibroblast growth factor, and their receptors in normal bone marrow. Acta Haematologica 2000;104:151–157.
  • Laughlin MJ, Barker J, Bambach B, Koc ON, Rizzieri DA, Wagner JE, Gerson S, Lazarus HM, Cairo M, Stevens CE, et al. Hematopoietic engraftment and survival in adult recipi-ents of umbilical-cord blood from unrelated donors. New England Journal of Medicine 2001;344:1815 —1822.
  • Devine SM, Lazarus HM, Emerson SG. Clinical application of hematopoietic progenitor cell expansion: current status and future prospects. Bone Marrow Transplantation 2003;31:241— 252.
  • Paquette RL, Dergham ST, Karpf E, Wang HJ, Slamon DJ, Souza L, Glaspy JA. Ex vivo expanded unselected peripheral blood: progenitor cells reduce posttransplantation neutrope-nia, thrombocytopenia, and anemia in patients with breast cancer. Blood 2000;96:2385 —2390.
  • Reiffers J, Cailliot C, Dazey B, Anal M, Caraux J, Boiron JM. Abrogation of post-myeloablative chemotherapy neutropenia by ex-vivo expanded autologous CD34-positive cells. Lancet 1999;354:1092— 1093.
  • McNiece I, Jones R, Bearman SI, Cagnoni P, Nieto Y, Franklin W, Ryder J, Steele A, Stoltz J, Russell P, et al. Ex vivo expanded peripheral blood progenitor cells provide rapid neutrophil recovery after high-dose chemotherapy in patients with breast cancer. Blood 2000;96;3001— 3007.
  • Rubinstein P, Dobrila L, Rosenfield RE, Adamson JW, Migliaccio G, Migliaccio AR, Taylor PE, Stevens CE. Processing and cryopreservation of placental/umbilical cord blood for unrelated bone marrow reconstitution. Proceedings of The National Academy of Sciences of The United States of America 1995;92:10119 —10122.
  • Rubinstein P, Carrier C, Scaradavou A, Kurtzberg J, Adamson J, Migliaccio AR, Berkowitz RL, Cabbad M, Dobrila NL, Taylor PE, et al. Outcomes among 562 recipients of placental blood transplants from unrelated donors. New England Journal of Medicine 1998;339:1565–1577.
  • Moscardo F, Sanz GF, Sanz MA. Unrelated-donor cord blood transplantation for adult hematological malignancies. Leukemia and Lymphoma 2004;45:11 —18.
  • Sirchia G, Rebulla P. Placental/umbilical cord blood transplantation. Haematologica 1999;84:738— 747.
  • Wagner JE. Umbilical cord transplantation. Leukemia 1998;12, Suppl 1:S30 — 32.
  • Benito Al, Diaz MA, Gonzalez-Vicent M, Sevilla J, Madero, L. Hematopoietic stem cell transplantation using umbilical cord blood progenitors: review of current clinical results. Bone Marrow Transplantation 2004;33:675— 690.
  • Gluckman E. Current status of umbilical cord blood hematopoietic stem cell transplantation. Experimental He-matology 2000;28:1197–1205.
  • Wagner JE, Rosenthal J, Sweetman R, Shu XO, Davies SM, Ramsay NK, McGlave PB, Sender L, Cairo MS. Successful transplantation of HLA-matched and HLA-mismatched umbilical cord blood from unrelated donors: analysis of engraftment and acute graft-versus-host disease. Blood 1996;88:795— 802.
  • Bachier CR, Gokmen E, Teale J, Lanzkron S, Childs C, Franklin W, Shpall E, Douville J, Weber S, Muller T, et al. Ex-vivo expansion of bone marrow progenitor cells for hematopoietic reconstitution following high-dose chemother-apy for breast cancer. Experimental Hematology 1999;27:615— 623.
  • Paquette RL, Dergham ST, Karpf E, Wang HJ, Slamon DJ, Souza L, Glaspy JA. Culture conditions affect the ability of ex vivo expanded peripheral blood progenitor cells to accelerate hematopoietic recovery. Experimental Hematology 2002;30:374 — 380.
  • da Silva CL, Goncalves R, Lemos F, Lemos MA, Zanjani ED, Almeida-Porada G, Cabral JM. Modelling of ex vivo expansion/maintenance of hematopoietic stem cells. Biopro-cess and Biosystems Engineering 2003;25:365–369.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.